Long-term endothelin receptor blockade improves cardiovascular function in diabetes

American Journal of Hypertension

Volumn 14, Issue 7 I, 2001, Pages 679-687

  Verma, Subodh ^a   Arikawa, Emi ^a   McNeill, John H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bosentan; Cardiac function; Endothelin receptor blocker; Endothelin 1; Streptozotocin induced diabetes; Vascular reactivity

Indexed keywords

BOSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; HEART FUNCTION; HEART PERFORMANCE; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MALE; MESENTERIC ARTERY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STREPTOZOCIN DIABETES;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ATRIAL FUNCTION, LEFT; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; MALE; MESENTERIC ARTERIES; MYOCARDIAL CONTRACTION; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; SULFONAMIDES; VASOCONSTRICTION;

EID: 0034952322     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)01302-4     Document Type: Article

References (36)

1. Risk factors for cardiovascular disease in IDDM. A study of identical twins
2. Physiological and pathological consequences of streptozotocin diabetes on the heart
3. Diabetic cardiomyopathy
4. Pathophysiology of endothelin in the cardiovascular system
5. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction
6. Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria
7. Insulin and vanadate restore decreased plasma endothelin concentrations and exaggerated vascular responses to normal in the streptozotocin diabetic rat
8. Impaired paracrine effect of endothelin-1 on vascular smooth muscle in streptozotocin-diabetic rats
9. Effect of chronic endothelin blockade in hyperinsulinemic hypertensive rats
10. Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts
11. Effect of diabetes on vascular smooth muscle function in normotensive and spontaneously hypertensive rat mesenteric artery
12. Protein kinase C-mediated contractile responses of arteries from diabetic rats
13. Vascular reactivity in streptozotocin-induced diabetes
14. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure
15. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects
16. Gene expression for endothelins and their receptors in glomeruli of diabetic rats
17. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells
18. Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes
19. Effects of chronic diabetes on the responsiveness to endothelin-1 and other agents of rat atria and thoracic aorta
20. Vascular biology of endothelin
21. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist
22. Influence of streptozotocin diabetes on the alpha-1 adrenoceptor and associated G proteins in rat arteries
23. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart
24. Cytotoxic effect of endothelin-1 during 'stimulated' ischaemia in cultured myocytes
25. Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway
26. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents
27. Differential effects of endothelin-1 on basal and isoprenaline-enhanced Ca2+ current in guinea-pig ventricular myocytes
28. Inhibition of cyclic AMP accumulation by endothelin is pertussis toxin sensitive and calcium independent in isolated adult feline cardiac myocytes
29. The arrhythmogenic action of endothelin in rats
30. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy
31. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
32. Endothelin antagonism with bosentan: A review of potential applications
33. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes
34. Diabetes-induced vascular dysfunction in the retina: Role of endothelins
35. Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes
36. Diabetes-induced myocardial structural changes: Role of endothelin-1 and its receptors